SpectraScience, Inc. to Hold Business Update Conference Call on November 10, 2011

SAN DIEGO, CA--(Marketwire - November 03, 2011) - SpectraScience, Inc. (OTCQB: SCIE), a San Diego based medical device company, today announced that it will hold a conference call on Thursday, November 10, 2011 at 4:30 p.m. Eastern (1:30 p.m. Pacific) to provide an update on its business and hold a question and answer session with investors.

Individuals interested in listening to the conference call may do so by dialing (877)-407-0782 for domestic callers, or (201)-689-8567 for international callers, or from the webcast link on the investor relations section of the Company’s Web site at www.spectrascience.com and at www.InvestorCalendar.com.

A telephone replay will be available through January 10, 2012 by dialing (877)-660-6853 for domestic callers, or (201)-612-7415 for international callers, and entering the Account #: 286, and the Conference ID #: 382238. The webcast will be available on the Company’s Web site for 90 days following the completion of the call.

About SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.